|2. Treat with a TNFi biologic over an IL-17i biologic (PICO 14)|Very low|
|Conditional recommendation based on very-low-quality evidence; may consider an IL-17i biologic if the patient has severe psoriasis or has contraindications to TNFi biologics, including congestive heart failure, previous serious infections, recurrent infections, or demyelinating disease.| |
|3. Treat with a TNFi biologic over an IL-12/23i biologic (PICO 13)|Very low|